NDA Full Form
(New Drug Application)
The New Drug Application (NDA) is the vehicle in the United States through which drug sponsors formally propose that the FDA approve a new pharmaceutical for sale and marketing.
Short Form | NDA |
Full Form | New Drug Application |
Category | Medical > Medicines & Drugs |
Country | United States |
Popularity | |
Other Full Form Of NDA
S.No. | Short Form | Full Form | Category | Country | Popularity |
1 |
NDA |
New Drug Application |
Medical > Medicines & Drugs |
United States |
|
2 |
NDA |
Non-Disclosure Agreement |
Business > Business Terms |
Worldwide |
|
3 |
NDA |
National Defence Academy |
Governmental > Military |
India |
|
4 |
NDA |
National Democratic Alliance |
Governmental > Politics |
India |
|
5 |
NDA |
Bandanaira Airport |
Transport & Travel > Airport Codes |
Indonesia |
|
Other Full Form list in same category - Airport Codes
S.No. | Short Form | Full Form | Country | Popularity |
1 |
NDA |
New Drug Application |
United States |
|
2 |
DIN |
Drug Identification Number |
Canada |
|
3 |
MMR |
Measles, Mumps, and Rubella |
Worldwide |
|
4 |
BCG |
Bacillus Calmette-Guerin |
Worldwide |
|
5 |
MRT |
Mean Residence Time |
Worldwide |
|
6 |
NDC |
National Drug Code |
United States |
|
7 |
PEN |
PENicillin |
Worldwide |
|
8 |
DPT |
Dipropyltryptamine |
Worldwide |
|
9 |
RNI |
Reference Nutrient Intake |
Worldwide |
|
10 |
SMR |
Skeletal Muscle Relaxant |
Worldwide |
|
11 |
MP |
Methylprednisolone |
Worldwide |
|
12 |
ADI |
Acceptable Daily Intake |
Worldwide |
|
13 |
PI |
Protease Inhibitors |
Worldwide |
|
14 |
OC |
Oral Contraceptive |
Worldwide |
|
15 |
IP |
International non-Proprietary name |
Worldwide |
|
16 |
BP |
British Pharmacopoeia |
United Kingdom |
|
17 |
ASA |
Acetylsalicylic Acid |
Worldwide |
|
18 |
CS |
Corticosteroids |
Worldwide |
|
19 |
EGCG |
Epigallocatechin Gallate |
Worldwide |
|
20 |
QTP |
Quetiapine |
Worldwide |
|
21 |
API |
Active Pharmaceutical Ingredient |
Worldwide |
|
22 |
IM |
Imatinib Mesylate |
Worldwide |
|
23 |
NRI |
Norepinephrine Reuptake Inhibitor |
Worldwide |
|
24 |
PIL |
Patient Information Leaflet |
Worldwide |
|
25 |
PV |
Pharmacovigilance |
Worldwide |
|
26 |
OD |
Overdose |
Worldwide |
|
27 |
ARV |
Anti-RetroViral |
Worldwide |
|
28 |
OTC |
Over The Counter |
Worldwide |
|
29 |
FDC |
Fixed Dose Combination |
Worldwide |
|
30 |
TTS |
Transdermal Therapeutic Systems |
Worldwide |
|
31 |
PK |
Pharmacokinetics |
Worldwide |
|
32 |
MAH |
Marketing Authorisation Holder |
Worldwide |
|
33 |
MDMA |
3,4-methylenedioxy-methamphetamine |
Worldwide |
|
34 |
DEC |
Diethylcarbamazine Citrate |
Worldwide |
|
35 |
BCS |
Biopharmaceutics Classification System |
Worldwide |
|
36 |
GC |
Glucocorticoid |
Worldwide |
|
37 |
Rx |
Prescription |
Worldwide |
|
38 |
GSF |
Griseofulvin |
Worldwide |
|
39 |
DPT |
Diphtheria, Pertussis, Tetanus |
Worldwide |
|
40 |
DOB |
Dimethoxybromoamphetamine |
Worldwide |
|
41 |
Dob |
Dobutamine |
Worldwide |
|
42 |
ED |
Effective Dose |
Worldwide |
|
43 |
UNII |
UNique Ingredient Identifier |
Worldwide |
|
44 |
RGJ |
Raw Garlic Juice |
Worldwide |
|
45 |
NSAID |
Non-Steroidal Anti-Inflammatory Drug(s) |
Worldwide |
|
46 |
AMP |
Amphetamine |
Worldwide |
|
47 |
Amp |
Ampicillin |
Worldwide |
|
48 |
tPA |
Tissue Plasminogen Activator |
Worldwide |
|
49 |
TPA |
Tetradecanoyl Phorbol Acetate |
Worldwide |
|
50 |
VPA |
Valproic Acid |
Worldwide |
|
51 |
BMI |
Bicuculline |
Worldwide |
|
52 |
TT |
Tetanus Toxoid |
Worldwide |
|
53 |
BTU |
Benzylthiouracil |
Worldwide |
|
54 |
NAC |
N-Acetylcysteine |
Worldwide |
|
55 |
NAC |
N-Acetylcarnosine |
Worldwide |
|
56 |
PMS |
Post-Market Surveillance |
Worldwide |
|
57 |
CPA |
Cyproterone acetate |
Worldwide |
|
58 |
CPA |
N6-Cyclopentyladenosine |
Worldwide |
|